STOCK TITAN

Mind Medicine (MNMD) Debt by Year

MNMD

Mind Medicine carried $40.6M in long-term debt against $257.8M in cash and equivalents at the end of fiscal year 2025. This represents an increase of 85.7% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Mind Medicine has filed alongside them.

FY2025 annual
Long-Term Debt $40.6M
Cash & Equivalents $257.8M
YoY +85.7%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

MNMD Debt & Cash by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY23FY22FY21FY20
Long-Term Debt$40.6M+85.7%$21.9M+54.7%$14.1MN/AN/AN/A
Cash & Equivalents$257.8M-5.8%$273.7M+174.6%$99.7M-29.9%$142.1M+6.4%$133.5M+66.7%$80.1M

MNMD Debt & Cash by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'24Q4'23Q3'23Q2'23
Long-Term Debt$40.8M+85.0%$40.6M+85.7%$40.4M+66.1%$41.2M+69.9%$22.0M+55.3%$21.9M+54.7%$24.3M+72.8%$24.3M$14.2M$14.1M$14.1MN/A
Cash & Equivalents$262.5M+216.8%$257.8M-5.8%$20.0M-93.2%$33.4M-86.3%$82.9M-67.2%$273.7M+174.6%$295.3M+150.9%$243.1M+108.0%$252.3M+95.0%$99.7M-29.9%$117.7M-23.8%$116.9M+10.5%

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More Mind Medicine financials

Frequently Asked Questions

What was Mind Medicine's long-term debt in fiscal year 2025?

Mind Medicine carried $40.6M in long-term debt against $257.8M in cash and equivalents at the end of fiscal year 2025.

How fast is Mind Medicine's long-term debt growing?

Mind Medicine (MNMD) long-term debt rose by 85.7% year over year, from $21.9M to $40.6M in fiscal year 2025.

What was Mind Medicine's long-term debt in the most recent quarter?

Mind Medicine (MNMD) reported $40.8M in long-term debt in Q1 2026. This represents an increase of 85.0% from the same quarter a year earlier.

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Mind Medicine (MNMD) reported on that line in every period on record.